IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge
By S. Khader, G. Bell, J. Pearl, Jeffrey J. Fountain, J. Rangel-Moreno, Garth E Cilley, F. Shen, Sheri M. Eaton, S. Gaffen, S. Swain and 4 more. Nature Immunology, 2007
1,498 citations recorded by the source corpus.
Subfields: Epidemiology, Immunology, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/847c954547852db285edfa6d0dfc3d21cf8c5a69
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- A. O’Garra
- F. Sallusto
- R. Wilkinson
- A. Lanzavecchia
- M. Berry
- Finlay W Mcnab
- Paul S. Redford
- C. Bloom
In Immunology
In Infectious Diseases
Citations in the corpus
- Th17 cell differentiation: the long and winding road. (2008, positive): “Prat and colleagues elegantly demonstrated that receptors for IL-17 and IL-22 are present on inflamed endothelium in MS lesions and that these cytokines may potentiate migration of inflammatory T cells across the blood-brain barrier ( Kebir et al., 2007 ).”
- The immune response in tuberculosis. (2013, background): “Following vaccination with a mycobacterial peptide, IL-17 is required for the accelerated recruitment of IFN-γ-producing cells to the lung, as a result of increased concentrations of the chemokines CXCL9, 10, and 11, which recruit cells to sites of inflammation (287).”
- Innate IL-17-producing cells: the sentinels of the immune system (2010, background): “Furthermore, there is increasing evidence that early IL-17 production may also influence the subsequent effector CD4 + T cell response, particularly T H 1 cell”